These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1194 related items for PubMed ID: 26497684

  • 1. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
    Gui Y, Liu H, Zhang L, Lv W, Hu X.
    Oncotarget; 2015 Nov 10; 6(35):37043-53. PubMed ID: 26497684
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
    Mo M, Xiao Y, Huang S, Cen L, Chen X, Zhang L, Luo Q, Li S, Yang X, Lin X, Xu P.
    Oncotarget; 2017 Jan 03; 8(1):15-28. PubMed ID: 27965467
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
    Riancho J, Vázquez-Higuera JL, Pozueta A, Lage C, Kazimierczak M, Bravo M, Calero M, Gonalezález A, Rodríguez E, Lleó A, Sánchez-Juan P.
    J Alzheimers Dis; 2017 Jan 03; 57(2):483-491. PubMed ID: 28269782
    [Abstract] [Full Text] [Related]

  • 4. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
    Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR.
    PLoS One; 2015 Jan 03; 10(10):e0139233. PubMed ID: 26426747
    [Abstract] [Full Text] [Related]

  • 5. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
    Uwatoko H, Hama Y, Iwata IT, Shirai S, Matsushima M, Yabe I, Utsumi J, Sasaki H.
    Mol Brain; 2019 May 14; 12(1):49. PubMed ID: 31088501
    [Abstract] [Full Text] [Related]

  • 6. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease.
    Dong Z, Gu H, Guo Q, Liang S, Xue J, Yao F, Liu X, Li F, Liu H, Sun L, Zhao K.
    Mol Neurobiol; 2021 Jul 14; 58(7):3084-3094. PubMed ID: 33629272
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Exosomal microRNA profiles from serum and cerebrospinal fluid in neurosyphilis.
    Chen H, Zhou Y, Wang ZY, Yan BX, Zhou WF, Wang TT, Zheng M, Man XY.
    Sex Transm Infect; 2019 Jun 14; 95(4):246-250. PubMed ID: 30926713
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease.
    McKeever PM, Schneider R, Taghdiri F, Weichert A, Multani N, Brown RA, Boxer AL, Karydas A, Miller B, Robertson J, Tartaglia MC.
    Mol Neurobiol; 2018 Dec 14; 55(12):8826-8841. PubMed ID: 29603092
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
    Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, Jahn H.
    PLoS One; 2015 Dec 14; 10(5):e0126423. PubMed ID: 25992776
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Tandem mass tag-based quantitative proteomics analysis of plasma and plasma exosomes in Parkinson's disease].
    Zhao Y, Liu X, Zhang Y, Zhang J, Liu X, Yang G.
    Se Pu; 2023 Dec 14; 41(12):1073-1083. PubMed ID: 38093537
    [Abstract] [Full Text] [Related]

  • 14. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
    Marques TM, Kuiperij HB, Bruinsma IB, van Rumund A, Aerts MB, Esselink RAJ, Bloem BR, Verbeek MM.
    Mol Neurobiol; 2017 Dec 14; 54(10):7736-7745. PubMed ID: 27844283
    [Abstract] [Full Text] [Related]

  • 15. The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer's Disease Biomarkers.
    Yang TT, Liu CG, Gao SC, Zhang Y, Wang PC.
    Biomed Environ Sci; 2018 Feb 14; 31(2):87-96. PubMed ID: 29606187
    [Abstract] [Full Text] [Related]

  • 16. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
    Cosín-Tomás M, Antonell A, Lladó A, Alcolea D, Fortea J, Ezquerra M, Lleó A, Martí MJ, Pallàs M, Sanchez-Valle R, Molinuevo JL, Sanfeliu C, Kaliman P.
    Mol Neurobiol; 2017 Sep 14; 54(7):5550-5562. PubMed ID: 27631879
    [Abstract] [Full Text] [Related]

  • 17. Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes.
    Yagi Y, Ohkubo T, Kawaji H, Machida A, Miyata H, Goda S, Roy S, Hayashizaki Y, Suzuki H, Yokota T.
    Neurosci Lett; 2017 Jan 01; 636():48-57. PubMed ID: 27780738
    [Abstract] [Full Text] [Related]

  • 18. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study.
    Manna I, Quattrone A, De Benedittis S, Vescio B, Iaccino E, Quattrone A.
    Parkinsonism Relat Disord; 2021 Dec 01; 93():77-84. PubMed ID: 34839044
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.
    Cao XY, Lu JM, Zhao ZQ, Li MC, Lu T, An XS, Xue LJ.
    Neurosci Lett; 2017 Mar 22; 644():94-99. PubMed ID: 28223160
    [Abstract] [Full Text] [Related]

  • 20. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
    Tan L, Yu JT, Tan MS, Liu QY, Wang HF, Zhang W, Jiang T, Tan L.
    J Alzheimers Dis; 2014 Mar 22; 40(4):1017-27. PubMed ID: 24577456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.